| Case | Sex Age | History | Eye | Refractive Error | BCVA | OCT | FA | Initial Management | Response |
| 1 | ♀ 48 y.o. | Insulin-dependent Diabetes Mellitus | OU | Low myopia | 20/200 (OU) | DSM with SRD (OU) | Early diffuse hyperfluorescence, atrophic changes. No leakage points. | Spironolactone 50 mg/day for 3 months | Stable |
| 2 | ♀ 45 y.o. | Corneal refractive surgery (OU) | OU | High myopia | OD: 20/70 OS: 20/50 | DSM with SRD (OU) | Early diffuse hyperfluorescence, atrophic changes. No leakage points. | Melatonin 9 mg/day for 1 month | Stable |
| 3 | ♂ 29 y.o. | Pseudophakia (OU) | OD | High myopia | OD: 20/30 OS: 20/40 | DSM with SRD (OD) DSM without SRD (OS) | Early diffuse hyperfluorescence, atrophic changes. No leakage points. | Observation | Stable |
| 4 | ♀ 68 y.o. | Corneal refractive surgery and pseudophakia (OU) | OS | High myopia | OD: 20/40 OS: 20/30 | DSM without SRD (OD) DSM with SRD (OS) | Early diffuse hyperfluorescence, atrophic changes. No leakage points. | Intravitreal anti-VEGF × 6 (OS) | Stable |
| 5 | ♀ 61 y.o. | Treatment with topiramate. Retinochoroidal coloboma (OS) | OU | Hyper-metropia | OD: 20/25 OS: 20/30 | DSM with SRD (OU) | Early diffuse hyperfluorescence, atrophic changes. No leakage points. | Observation | Stable |